Basal Nucleus Of Meynert (Expanded) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Basal Nucleus of Meynert (NBM), also known as the Nucleus Basalis or Ch4, is the largest collection of cholinergic neurons in the basal forebrain. It provides the primary source of cortical acetylcholine and plays essential roles in attention, learning, memory, and arousal. The NBM is strategically positioned in the substantia innominata, with widespread projections to the entire neocortex, hippocampus, and amygdala. Degeneration of the NBM is a hallmark of Alzheimer's disease and contributes to cognitive decline in various dementias. The NBM serves as a critical therapeutic target for cholinergic replacement therapies and deep brain stimulation approaches. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000646 | basal cell |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000646 | basal cell | Medium |
| Cell Ontology | CL:2000056 | Meynert cell | Medium |
The Basal Nucleus of Meynert (NBM) is the largest collection of cholinergic neurons in the basal forebrain and provides the primary source of cortical acetylcholine. It plays essential roles in attention, learning, memory, and arousal. Degeneration of the NBM is a hallmark of Alzheimer's disease and contributes to cognitive decline in various dementias.
The Basal Nucleus of Meynert (NBM) is the largest collection of cholinergic neurons in the basal forebrain. It provides the primary source of cortical acetylcholine and plays essential roles in attention, learning, memory, and arousal. Degeneration of the NBM is a hallmark of Alzheimer's disease and contributes to cognitive decline in various dementias[2].
The Basal Nucleus of Meynert consists of large, medium-sized cholinergic neurons:
The NBM is essential for cortical activation and cognitive processing:
The NBM is prominently affected in several neurodegenerative conditions:
Single-nucleus RNA sequencing reveals distinct NBM populations:
The NBM is a major therapeutic target:
Key research priorities:
The study of Basal Nucleus Of Meynert (Expanded) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[2] M.-M. M. Mesulam, "Basal forebrain cholinergic dysfunction in Alzheimer's disease - relationship to cortical histopathology," Brain, vol. 135, no. 6, pp. 1815-1829, 2012. Brain. 2012. ↩︎ ↩︎
[1] E. K. J. H. Whitehouse, "The nucleus basalis of Meynert: normal anatomy, pathology, and function," Brain Research, vol. 472, no. 4, pp. 299-315, 1988. Brain Research. 1988. ↩︎